IGM Biosciences, Inc. (IGMS) Q2 Earnings and Revenues Surpass Estimates

IGMS Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of IGM Biosciences, Inc. is Fair to Shareholders

IGM Biosciences Enters into Agreement to Be Acquired by Concentra Biosciences for $1.247 in Cash per Share Plus a Contingent Value Right

IGM Biosciences, Inc. (IGMS) Reports Q1 Loss, Misses Revenue Estimates

IGM Biosciences, Inc. (IGMS) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Down -76.91% in 4 Weeks, Here's Why IGM Biosciences (IGMS) Looks Ripe for a Turnaround

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of IGM Biosciences, Inc. - IGMS

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of IGM Biosciences, Inc. - IGMS

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of IGM Biosciences, Inc. - IGMS

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of IGM Biosciences, Inc. - IGMS

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of IGM Biosciences, Inc. - IGMS

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of IGM Biosciences, Inc. - IGMS

IGMS STOCK ALERT: Levi & Korsinsky Notifies IGM Biosciences, Inc. Investors of an Ongoing Investigation

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of IGM Biosciences, Inc. - IGMS

IGM Biosciences downgraded to Hold from Buy at Stifel

IGM Biosciences downgraded to Underweight from Equal Weight at Morgan Stanley

IGM Biosciences downgraded to Market Perform from Outperform at BMO Capital

IGM Biosciences to cut 73% of workforce as latest pivot fails to pan out

IGM Biosciences Provides Strategic Update on Autoimmunity Pipeline Programs

IGM Biosciences, Inc. (IGMS) Reports Q3 Loss, Tops Revenue Estimates

IGM Biosciences Announces Third Quarter 2024 Financial Results and Provides Corporate Update

IGM Biosciences to Present at Three Upcoming Investor Conferences

IGM Biosciences' stock tumbles as analysts weigh in on pivot plan with dismay

IGM Biosciences' New Found Focus: Pivots From Cancer To Autoimmune Diseases, Names New CEO

IGM Biosciences Stock Drops 27% on ‘Pipeline Transformation' to Autoimmune Diseases

IGM Biosciences, CPI Card And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

IGM Biosciences Announces Strategic Pivot to Focus Exclusively on Autoimmunity

IGM Biosciences (IGMS) Surges 11.6%: Is This an Indication of Further Gains?

IGM Biosciences to Present at the Stifel 2024 Virtual Immunology and Inflammation Summit

All You Need to Know About IGM Biosciences (IGMS) Rating Upgrade to Buy

IGM Biosciences, Inc. (IGMS) Reports Q2 Loss, Lags Revenue Estimates

IGM Biosciences Announces Second Quarter 2024 Financial Results and Provides Corporate Update

IGM Biosciences (IGMS) Soars 32.7%: Is Further Upside Left in the Stock?

IGM Biosciences to Present at the Jefferies Healthcare Conference

IGM Biosciences, Inc. (IGMS) Reports Q1 Loss, Misses Revenue Estimates

IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Update

IGM Biosciences to Present at the 2024 RBCCM Global Healthcare Conference

IGM Biosciences, Inc. (IGMS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

IGM Biosciences (IGMS) Upgraded to Buy: What Does It Mean for the Stock?

IGM Biosciences Announces Refocusing of Sanofi Collaboration

IGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology Forum

IGM Biosciences, Inc. (IGMS) Reports Q4 Loss, Lags Revenue Estimates

IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Wall Street Analysts Think IGM Biosciences, Inc. (IGMS) Could Surge 63.1%: Read This Before Placing a Bet

Wall Street Analysts Believe IGM Biosciences, Inc. (IGMS) Could Rally 35.08%: Here's is How to Trade

IGM Biosciences: Imvotamab Data 2nd Half Of 2024 With Other Inflection Points

IGM Biosciences to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

IGM Bio (IGMS) Stock Rallies 142% in 3 Months: Here's Why

IGM Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Medivir to present at the Carlsquare Equity Research Investor Day